Indegene transformed automated case intake and processing for a top-3 US multinational pharma and biotech company committed to equitable access to quality medicines across developed and emerging markets. Confronting a surge of up to 1.2 million nonserious cases in six months, manual processes taking 45-50 minutes per case (mostly ICSR identification), and high operational costs, Indegene's intelligent automation software revolutionized workflows. It slashed processing times dramatically, handled massive volumes scalably, minimized manual effort, cut costs significantly, and boosted accuracy—enabling efficient management of feared diseases for a healthier global impact.

Join for free to read